FINANCIALS

ANIP Ani Pharmaceuticals Inc 1023024

Income Statement
Revenue	anip-20240930	148,332,000
Net Income	anip-20240930	-24,166,000
Profit Margin		-16.29%

Balance Sheet
Current Assets	521,297,000
Assets	1,287,377,000
Current Liabilities	189,933,000
Liabilities	881,429,000
Equity	405,948,000
Shares Out	21,030,000

Cash Flow Statement
Operating Cash Flow	48,157,000
Investing Cash Flow	-394,038,000

Market Analysis
Market Cap	1,281,677,000
Price	58.46
BVPS	19.30
PB	3.01
EPS	1.19
PE	51.25
PS	2.16
FCF	-345,881,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ANIP documents filed with the SEC.

ANIP Filings Clear

View A List of Tickers